A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice.
- Resource Type
- Article
- Source
- Vaccines; Jul2022, Vol. 10 Issue 7, pN.PAG-N.PAG, 14p
- Subject
CANCER vaccines PROGRAMMED death-ligand 1 CYTOTOXIC T cells IMMUNE checkpoint proteins IMMUNITY PANCREATIC tumors - Language
- ISSN
- 2076393X